InsidersTradesSigma
Track the Avadel Pharmaceuticals PLC share price and the full management transaction log of the company, a publicly traded company based in United States. Shares trade on the US market, under the authority of SEC (Form 4). Operating in the Health Care sector, Avadel Pharmaceuticals PLC has published 56 reports. The latest transaction was reported on 18 February 2026 (Cession). Among the most active insiders: Palczuk Linda. The full history is free.
56
Insider Decl.
n/a
Thresholds
€2m
27 ops.
Buy Volume
€212m
12 ops.
Sell Volume
48Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 18 February 2026
Declarations56 total
11,112,052 shares@ US$21.00100.0% of flowOrdinary SharesSEC:0001357550-26-000015:0
115,060 shares@ US$21.0092.8% of flowOrdinary SharesSEC:0001104659-26-014448:0
23,496 shares@ US$21.00100.0% of flowOrdinary SharesSEC:0001104659-26-014447:0
78,905 shares@ US$21.0091.5% of flowOrdinary SharesSEC:0001104659-26-014446:0
100,400 shares@ US$21.0087.1% of flowOrdinary SharesSEC:0001104659-26-014445:0
22,000 shares@ US$21.0022.1% of flowOrdinary SharesSEC:0001104659-26-014444:0
22,005 shares@ US$21.0041.9% of flowOrdinary SharesSEC:0001104659-26-014443:0
219,905 shares@ US$21.0086.4% of flowOrdinary SharesSEC:0001104659-26-014442:0
211,105 shares@ US$21.0092.3% of flowOrdinary SharesSEC:0001104659-26-014441:0
22,000 shares@ US$21.00100.0% of flowOrdinary SharesSEC:0001104659-26-014438:0
67,025 shares0Ordinary SharesSEC:0001104659-26-011511:0
11,000 shares0Ordinary SharesSEC:0001104659-25-072695:0
11,000 shares0Ordinary SharesSEC:0001104659-25-072692:0
11,000 shares0Ordinary SharesSEC:0001104659-25-072687:0
11,000 shares0Ordinary SharesSEC:0001104659-25-072686:0
11,000 shares0Ordinary SharesSEC:0001104659-25-072685:0
11,000 shares0Ordinary SharesSEC:0001104659-25-072682:0
52,000 shares0Ordinary SharesSEC:0001104659-25-021732:0
14,700 shares0Ordinary SharesSEC:0001104659-25-021736:0
12,600 shares0Ordinary SharesSEC:0001104659-25-021733:0
5,000 shares@ US$7.92829.5% of flowOrdinary SharesSEC:0001104659-25-005248:0
Canonical exit: 21 Apr 2025 (T+90)
10,000 shares@ US$8.04549.9% of flowOrdinary SharesSEC:0001104659-25-003452:0
Canonical exit: 13 Apr 2025 (T+90)
30,000 shares@ US$7.840637.4% of flowOrdinary SharesSEC:0001104659-25-003451:0
Canonical exit: 13 Apr 2025 (T+90)
3,500 shares0Ordinary SharesSEC:0001104659-24-132145:0
2,300 shares@ US$10.44298.7% of flowOrdinary SharesSEC:0001104659-24-128666:0
Canonical exit: 13 Mar 2025 (T+90)
25 of 56 declarations
关于 Avadel Pharmaceuticals PLC
Avadel Pharmaceuticals PLC 是一家生物制药公司，专注于开发治疗睡眠障碍和其他疾病的创新疗法。该公司在纳斯达克上市，股票代码为 AVDL。